Foundry Partners’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-720,540
| Closed | -$1.44M | – | 396 |
|
|
2019
Q2 | $1.44M | Buy |
720,540
+196,375
| +37% | +$393K | 0.06% | 295 |
|
|
2019
Q1 | $2.26M | Sell |
524,165
-4,925
| -0.9% | -$21.2K | 0.09% | 261 |
|
|
2018
Q4 | $1.68M | Buy |
529,090
+119,065
| +29% | +$379K | 0.08% | 286 |
|
|
2018
Q3 | $2.15M | Sell |
410,025
-11,265
| -3% | -$59.2K | 0.08% | 277 |
|
|
2018
Q2 | $2.25M | Sell |
421,290
-237,290
| -36% | -$1.27M | 0.09% | 266 |
|
|
2018
Q1 | $3.29M | Sell |
658,580
-72,765
| -10% | -$364K | 0.14% | 218 |
|
|
2017
Q4 | $2.41M | Sell |
731,345
-23,475
| -3% | -$77.5K | 0.1% | 248 |
|
|
2017
Q3 | $2.83M | Buy |
754,820
+70,045
| +10% | +$263K | 0.11% | 274 |
|
|
2017
Q2 | $1.75M | Buy |
684,775
+18,575
| +3% | +$47.4K | 0.07% | 314 |
|
|
2017
Q1 | $1.73M | Buy |
666,200
+38,750
| +6% | +$101K | 0.07% | 323 |
|
|
2016
Q4 | $1.91M | Buy |
627,450
+121,400
| +24% | +$370K | 0.08% | 313 |
|
|
2016
Q3 | $1.38M | Buy |
506,050
+125
| +0% | +$340 | 0.07% | 290 |
|
|
2016
Q2 | $1.45M | Buy |
505,925
+1,475
| +0.3% | +$4.22K | 0.08% | 286 |
|
|
2016
Q1 | $1.52M | Buy |
504,450
+16,450
| +3% | +$49.7K | 0.15% | 176 |
|
|
2015
Q4 | $1.69M | Buy |
488,000
+22,695
| +5% | +$78.7K | 0.14% | 174 |
|
|
2015
Q3 | $1.76M | Buy |
465,305
+154,786
| +50% | +$585K | 0.15% | 169 |
|
|
2015
Q2 | $1.77M | Buy |
310,519
+51,599
| +20% | +$294K | 0.14% | 171 |
|
|
2015
Q1 | $1.51M | Buy |
+258,920
| New | +$1.51M | 0.13% | 168 |
|